Literature DB >> 25044633

The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.

M K Svensson1, M Tyrberg, L Nyström, H J Arnqvist, J Bolinder, J Östman, S Gudbjörnsdottir, M Landin-Olsson, J W Eriksson.   

Abstract

AIMS: The main objective of this study was to estimate the occurrence of diabetic nephropathy in a population-based cohort of patients diagnosed with diabetes as young adults (15-34 years).
METHODS: All 794 patients registered 1987-1988 in the Diabetes Incidence Study in Sweden (DISS) were invited to a follow-up study 15-19 years after diagnosis, and 468 (58%) participated. Analysis of islet antibodies was used to classify type of diabetes.
RESULTS: After median 17 years of diabetes, 15% of all patients, 14% T1DM and 25% T2DM, were diagnosed with diabetic nephropathy. Ninety-one percent had microalbuminuria and 8.6% macroalbuminuria. Older age at diagnosis (HR 1.05; 95% CI 1.01-1.10 per year) was an independent and a higher BMI at diabetes diagnosis (HR 1.04; 95% CI 1.00-1.09 per 1 kg/m²), a near-significant predictor of development of diabetic nephropathy. Age at onset of diabetes (p = 0.041), BMI (p = 0.012) and HbA1c (p < 0.001) were significant predictors of developing diabetic nephropathy between 9 and 17 years of diabetes. At 17 years of diabetes duration, a high HbA1c level (OR 1.06; 95% CI 1.03-1.08 per 1 mmol/mol increase) and systolic blood pressure (OR 1.08; 95% CI 1.05 1.12 per 1 mmHg increase) were associated with DN.
CONCLUSIONS: Patients with T2DM diagnosed as young adults seem to have an increased risk to develop diabetic nephropathy compared with those with T1DM. Older age and higher BMI at diagnosis of diabetes were risk markers for development of diabetic nephropathy. In addition, poor glycaemic control but not systolic blood pressure at 9 years of follow-up was a risk marker for later development of diabetic nephropathy.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  blood pressure; diabetic nephropathy; hyperglycaemia; islet antibodies; type 1 diabetes mellitus; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2014        PMID: 25044633     DOI: 10.1002/dmrr.2574

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  8 in total

Review 1.  Developing Treatments for Chronic Kidney Disease in the 21st Century.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Semin Nephrol       Date:  2016-11       Impact factor: 5.299

2.  Study on the Risk Factors for Hyperuricaemia and Related Vascular Complications in Patients with Type 2 Diabetes Mellitus.

Authors:  Rong Shi; Zheyun Niu; Birong Wu; Fan Hu
Journal:  Risk Manag Healthc Policy       Date:  2020-09-21

3.  Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis.

Authors:  Yan Hong; Zhihong Gui; Xiaoping Cai; Lejian Lan
Journal:  Open Med (Wars)       Date:  2016-12-30

4.  BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.

Authors:  Elli Polemiti; Julia Baudry; Olga Kuxhaus; Susanne Jäger; Manuela M Bergmann; Cornelia Weikert; Matthias B Schulze
Journal:  Diabetologia       Date:  2021-01-15       Impact factor: 10.122

5.  Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study.

Authors:  Robin Kristófi; Johan Bodegard; Anna Norhammar; Marcus Thuresson; David Nathanson; Thomas Nyström; Kåre I Birkeland; Jan W Eriksson
Journal:  Diabetes Care       Date:  2021-03-02       Impact factor: 19.112

6.  Retinol-binding protein 4 versus albuminuria as predictors of estimated glomerular filtration rate decline in patients with type 2 diabetes.

Authors:  Aleksandra Klisic; Nebojsa Kavaric; Ana Ninic
Journal:  J Res Med Sci       Date:  2018-05-30       Impact factor: 1.985

7.  Nomogram for the prediction of diabetic nephropathy risk among patients with type 2 diabetes mellitus based on a questionnaire and biochemical indicators: a retrospective study.

Authors:  Yuhong Hu; Rong Shi; Ruohui Mo; Fan Hu
Journal:  Aging (Albany NY)       Date:  2020-06-02       Impact factor: 5.682

8.  A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.

Authors:  Xintian Cai; Qing Zhu; Yuanyuan Cao; Shasha Liu; Mengru Wang; Ting Wu; Jing Hong; Ayguzal Ahmat; Xiayire Aierken; Nanfang Li
Journal:  Biomed Res Int       Date:  2021-05-14       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.